134 related articles for article (PubMed ID: 29665655)
1. MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1.
Zhang X; Wang L; Liu Y; Huang W; Cheng D
Biomed Pharmacother; 2018 Mar; 99():523-529. PubMed ID: 29665655
[TBL] [Abstract][Full Text] [Related]
2. miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.
Incoronato M; Garofalo M; Urso L; Romano G; Quintavalle C; Zanca C; Iaboni M; Nuovo G; Croce CM; Condorelli G
Cancer Res; 2010 May; 70(9):3638-46. PubMed ID: 20388802
[TBL] [Abstract][Full Text] [Related]
3. miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
Zhu X; Li D; Yu F; Jia C; Xie J; Ma Y; Fan S; Cai H; Luo Q; Lv Z; Fan L
Oncotarget; 2016 Mar; 7(11):13139-52. PubMed ID: 26909612
[TBL] [Abstract][Full Text] [Related]
4. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p.
Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891
[TBL] [Abstract][Full Text] [Related]
5. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
Acunzo M; Visone R; Romano G; Veronese A; Lovat F; Palmieri D; Bottoni A; Garofalo M; Gasparini P; Condorelli G; Chiariello M; Croce CM
Oncogene; 2012 Feb; 31(5):634-42. PubMed ID: 21706050
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-219 is downregulated in non-small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2.
Sun X; Xu M; Liu H; Ming K
Mol Med Rep; 2017 Sep; 16(3):3557-3564. PubMed ID: 28714014
[TBL] [Abstract][Full Text] [Related]
7. Apigenin potentiates TRAIL therapy of non-small cell lung cancer via upregulating DR4/DR5 expression in a p53-dependent manner.
Chen M; Wang X; Zha D; Cai F; Zhang W; He Y; Huang Q; Zhuang H; Hua ZC
Sci Rep; 2016 Oct; 6():35468. PubMed ID: 27752089
[TBL] [Abstract][Full Text] [Related]
8. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.
Romano G; Acunzo M; Garofalo M; Di Leva G; Cascione L; Zanca C; Bolon B; Condorelli G; Croce CM
Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16570-5. PubMed ID: 23012423
[TBL] [Abstract][Full Text] [Related]
9. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.
Sun C; Li S; Yang C; Xi Y; Wang L; Zhang F; Li D
Biochem Biophys Res Commun; 2016 Feb; 471(1):82-8. PubMed ID: 26845350
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC.
Joshi P; Jeon YJ; Laganà A; Middleton J; Secchiero P; Garofalo M; Croce CM
Proc Natl Acad Sci U S A; 2015 Jul; 112(28):8650-5. PubMed ID: 26124099
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14.
Yu F; Liu JB; Wu ZJ; Xie WT; Zhong XJ; Hou LK; Wu W; Lu HM; Jiang XH; Jiang JJ; Cao ZY; Cong GJ; Shi MX; Jia CY; Lu GX; Song YC; Chai L; Lv ZW; Wu CY; Ma YS; Fu D
Cancer Lett; 2018 Jul; 427():74-84. PubMed ID: 29702194
[TBL] [Abstract][Full Text] [Related]
13. miR-144-5p Enhances the Radiosensitivity of Non-Small-Cell Lung Cancer Cells via Targeting ATF2.
Song L; Peng L; Hua S; Li X; Ma L; Jie J; Chen D; Wang Y; Li D
Biomed Res Int; 2018; 2018():5109497. PubMed ID: 29850528
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2.
Huang P; Ye B; Yang Y; Shi J; Zhao H
Tumour Biol; 2015 May; 36(5):3381-7. PubMed ID: 25524579
[TBL] [Abstract][Full Text] [Related]
15. The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.
Qian Z; Yang J; Liu H; Yin Y; Hou L; Hu H
Folia Histochem Cytobiol; 2019; 57(2):64-73. PubMed ID: 31246264
[TBL] [Abstract][Full Text] [Related]
16. MiR-95 induces proliferation and chemo- or radioresistance through directly targeting sorting nexin1 (SNX1) in non-small cell lung cancer.
Chen X; Chen S; Hang W; Huang H; Ma H
Biomed Pharmacother; 2014 Jun; 68(5):589-95. PubMed ID: 24835695
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the death-associated protein kinase promoter attenuates the sensitivity to TRAIL-induced apoptosis in human non-small cell lung cancer cells.
Tang X; Wu W; Sun SY; Wistuba II; Hong WK; Mao L
Mol Cancer Res; 2004 Dec; 2(12):685-91. PubMed ID: 15634757
[TBL] [Abstract][Full Text] [Related]
18. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
19. miR-30a-5p enhances paclitaxel sensitivity in non-small cell lung cancer through targeting BCL-2 expression.
Xu X; Jin S; Ma Y; Fan Z; Yan Z; Li W; Song Q; You W; Lyu Z; Song Y; Shi P; Liu Y; Han X; Li L; Li Y; Liu Y; Ye Q
J Mol Med (Berl); 2017 Aug; 95(8):861-871. PubMed ID: 28487996
[TBL] [Abstract][Full Text] [Related]
20. miR-20a-directed regulation of BID is associated with the TRAIL sensitivity in colorectal cancer.
Huang G; Chen X; Cai Y; Wang X; Xing C
Oncol Rep; 2017 Jan; 37(1):571-578. PubMed ID: 28004114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
